Key facts
- This page summarizes Clay Thorp's Form 4 filing for Vigil Neuroscience, Inc. (VIGL).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 11 Jan 2022, 20:20.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Conversion of derivative security
Purchase
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Conversion of derivative security
Conversion of derivative security
Additional SEC filing notes
Footnote F1
Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") on a one-for-2.7732 basis upon the closing of the Issuer's initial public offering on January 1, 2022 and had no expiration date.
Footnote F2
The shares are held directly by Hatteras Venture Partners VI, L.P. ("Hatteras VI"). Hatteras Venture Advisors VI, LLC ("HVA VI") is the general partner of Hatteras VI. The Reporting Person is a managing member of HVA VI and disclaims beneficial ownership of the shares held by Hatteras VI except to the extent of his pecuniary interest therein, if any.
Footnote F3
On January 11, 2022, Hatteras VI purchased 265,000 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.